GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (Q9NAA5)

Analyse AlphaFold monomer V2.0 prediction for cap-specific mRNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9NAA5
Type
protein
Length
918 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xe31a910f6C16a75742b91e7617931F9bE87c1D6c
Molecule
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
UniProt
Q9NAA5
Pockets
11 · best druggability 0.77

Structure

1 distinct chain · 36% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1protein91836% helix, 18% strandQ9NAA5

Pockets

11 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12580.770.9048empty
210220.770.7980empty
31480.660.8724empty
42060.570.8025empty
54340.560.7434empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.